| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872020 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 10 Pages |
Abstract
Conclusion: Lymph node metastasis from HCC is sensitive to EBRT. EBRT with 25 fractions of 2 Gy is an effective palliative treatment for patients with LN metastases from HCC presenting with good performance status and may prolong overall survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Zhao-Chong M.D., Zhao-You M.D., Jia M.D., Lun-Xiu M.D., Shen-Long M.D., Jian M.D., Hui-Chuan M.D., Bin-Liang M.D., Jian-Hua M.D.,